# CALLIDITAS THERAPEUTICS AB (CALT)

> Institutional ownership reported to the SEC as of Q3 2024, from Form 13F filings. Source: https://holderbook.com/stocks/CALT/

- Reporting holders: 5
- Reported value: $765.1K
- Held through calls: 0.0%
- Held through puts: 2.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Crossmark Global Holdings, Inc.](https://holderbook.com/funds/1539204-crossmark-global-holdings-inc/) | $655.0K | 16,117 | 0.0% | 1 |
| [Advisors Preferred, LLC](https://holderbook.com/funds/1598841-advisors-preferred-llc/) | $81.5K | 2,022 | 0.0% | 1 |
| [SIMPLEX TRADING, LLC](https://holderbook.com/funds/1488542-simplex-trading-llc/) | $15.0K | 0 | 0.0% | 9 |
| [RHUMBLINE ADVISERS](https://holderbook.com/funds/1115418-rhumbline-advisers/) | $12.2K | 303 | 0.0% | 6 |
| [Missouri Trust & Investment Co](https://holderbook.com/funds/1908186-missouri-trust-investment-co/) | $1.4K | 35 | 0.0% | 12 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2024 | 5 | $765.1K |
| Q2 2024 | 20 | $33.7M |
| Q1 2024 | 19 | $19.8M |
| Q4 2023 | 22 | $23.6M |
| Q3 2023 | 18 | $16.9M |
| Q2 2023 | 16 | $14.1M |
| Q1 2023 | 16 | $21.9M |
| Q4 2022 | 18 | $16.0M |
| Q3 2022 | 17 | $14.0M |
| Q2 2022 | 16 | $15.6M |
| Q1 2022 | 19 | $16.9M |
| Q4 2021 | 20 | $31.2M |